Page 22 - Gates-AnnualReport-2015

COMMERCIALIZATION
Professor of Pathology and John S. Gates Endowed Chair in Stem Cell Biology Xiao-Jing Wang, MD, PhD, presents to the Gates Advisory Board.
The Gates Center is committed to bringing the world’s brightest innovators together to accelerate the movement of regenerative medicine into clinical trials and commercialized therapies.
As a team, we encompass the dynamic creativity, scientific intelligence and industry experience needed to realize the true potential of breakthrough technologies. To that end, we strive to help our members translate their discoveries into commercialization opportunities for the benefit of the inventor, the University of Colorado and our community as a whole.
Highlights from our 2015 efforts include the following:
Allander Biotechnologies
Allander Biotechnologies, LLC, formed in 2014, is a start-up company fostered by the Gates Center for Regenerative Medicine, which has developed biologics to treat at least four diseases:
• Oral mucositis: a frequent side effect for cancer patients undergoing radiation and chemotherapy.
• Psoriasis: the most prevalent autoimmune disease in the U.S., with as many as 7.5 million Americans and 125 million people
worldwide affected.
22 Gates Center for Regenerative Medicine